Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

10.53

+0.01 (0.10%)

At close: Aug 5, 2026, 4:00 PM EDT

10.39

-0.14 (-1.33%)

After-hours: Aug 5, 2026, 7:50 PM EDT

Zevra Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	58.26	83.23	-105.51	-46.05	-26.77	-8.56
Depreciation & Amortization	1.49	4.05	6.39	1.01	0.94	0.26
Stock-Based Compensation	13.13	12.63	14.91	5.95	4.29	2.44
Other Adjustments	-35.82	-75	21.74	-0.33	3.22	16.66
Change in Receivables	-3.86	-11.98	6.87	-9.08	-6.77	1.05
Changes in Inventories	-1.04	-1.31	-8.87	0.21	0.15	-
Changes in Accounts Payable	-2.53	-15.59	-3.6	11.13	3.13	-1.11
Changes in Other Operating Activities	2.91	2.36	-1.59	3.63	3.09	-0.3
Operating Cash Flow	33.4	-1.6	-69.67	-33.54	-18.72	10.44
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-0.78	-0.84	-	-0.3	-0.09	-0.1
Sale of Property, Plant & Equipment	-	0.45	-	-	-	-
Proceeds from Sale of Intangible Assets	48.94	150	-	-	-	-
Purchases of Investments	-233.11	-309.99	-41.16	-45.81	-23.86	-15.42
Proceeds from Sale of Investments	291.22	178.5	25	59.12	1.33	-
Cash Acquisitions	-	-	-	-30.4	-14.09	-
Other Investing Activities	-	-	-6	-	-	-
Investing Cash Flow	106.72	18.13	-22.16	-17.39	-36.72	-15.52
Long-Term Debt Issued	-	-	58.99	42.43	12.8	-
Long-Term Debt Repaid	-60.09	-	-42.7	-17.53	-	-37.92
Net Long-Term Debt Issued (Repaid)	-60.09	-	16.29	24.9	12.8	-37.92
Issuance of Common Stock	19.43	12.44	67.26	6.32	0.32	158.24
Repurchase of Common Stock	-	-	-	-3.45	-4.72	-2.81
Net Common Stock Issued (Repurchased)	19.43	12.44	67.26	2.88	-4.4	155.43
Other Financing Activities	-1.49	-0.37	-1.44	0.69	-0.05	-4.39
Financing Cash Flow	-42.14	12.06	82.11	28.46	8.35	113.11
Foreign Exchange Rate Adjustments	-0.37	0.03	0.45	0.04	0.2	-
Net Cash Flow	97.61	28.62	-9.26	-22.42	-46.88	108.02
Free Cash Flow	32.62	-2.43	-69.67	-33.83	-18.81	10.34
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	23.98%	-2.29%	-295.04%	-123.20%	-179.86%	36.08%
Free Cash Flow Per Share	0.55	-0.04	-1.51	-0.95	-0.55	0.35
Levered Free Cash Flow	-60.59	71.91	-96.89	-5.48	-21.53	-102.07
Unlevered Free Cash Flow	-889.72	-76.76	-79.84	-33.93	-36.08	6.45

SEC Filings: 10-K · 10-Q